STOCK TITAN

AirSculpt Technologies Announces Leadership Changes

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

AirSculpt Technologies, Inc. (NASDAQ:AIRS), a national provider of premium body contouring procedures, has announced significant leadership changes. Todd Magazine has stepped down as Chief Executive Officer and Board member, transitioning to an advisory role until December 31, 2024. Dennis Dean, the company's Chief Financial Officer, has been appointed as interim CEO while a search for a permanent successor is conducted.

Dr. Aaron Rollins, Executive Chairman, expressed confidence in the company's business model and growth potential. The focus will be on core body contouring procedures, reducing long-term marketing spend, and increasing fiscal discipline in response to the current economic environment. Dennis Dean emphasized the company's plan to focus on core operations, reduce expenses, and position for efficient scaling to deliver consistent revenue growth with industry-leading EBITDA margins as conditions improve.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), un fornitore nazionale di procedure di modellamento del corpo premium, ha annunciato significative modifiche nelle sue leadership. Todd Magazine si è dimesso dal ruolo di Amministratore Delegato e membro del Consiglio, passando a un ruolo di consulente fino al 31 dicembre 2024. Dennis Dean, il Chief Financial Officer dell'azienda, è stato nominato Amministratore Delegato ad interim mentre viene condotta la ricerca di un successore permanente.

Il Dr. Aaron Rollins, Presidente Esecutivo, ha espresso fiducia nel modello di business dell'azienda e nel suo potenziale di crescita. L'attenzione sarà posta su procedure di modellamento del corpo fondamentali, riduzione della spesa pubblicitaria a lungo termine e aumento della disciplina fiscale in risposta all'attuale ambiente economico. Dennis Dean ha sottolineato il piano dell'azienda di concentrarsi sulle operazioni principali, ridurre le spese e posizionarsi per una scalabilità efficiente per garantire una crescita dei ricavi costante con margini EBITDA leader nel settore man mano che le condizioni migliorano.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), un proveedor nacional de procedimientos de contorno corporal premium, ha anunciado cambios significativos en su liderazgo. Todd Magazine ha renunciado a su puesto como Director Ejecutivo y miembro de la Junta, pasando a un rol asesor hasta el 31 de diciembre de 2024. Dennis Dean, el Director Financiero de la empresa, ha sido nombrado Director Ejecutivo interino mientras se busca un sucesor permanente.

El Dr. Aaron Rollins, Presidente Ejecutivo, expresó confianza en el modelo de negocio de la empresa y su potencial de crecimiento. El enfoque estará en procedimientos de contorno corporal fundamentales, reducción del gasto en marketing a largo plazo y aumento de la disciplina fiscal en respuesta al actual entorno económico. Dennis Dean enfatizó el plan de la empresa para enfocarse en las operaciones centrales, reducir gastos y posicionarse para una escalabilidad eficiente para lograr un crecimiento de ingresos constante con márgenes EBITDA líderes en la industria a medida que mejoran las condiciones.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), 프리미엄 바디 윤곽 절차의 국가 제공업체가 중요한 리더십 변화를 발표했습니다. 타드 매거진이 최고경영자(CEO) 및 이사회 멤버직에서 사임했습니다, 2024년 12월 31일까지 자문 역할로 전환합니다. 덴니스 딘, 회사의 최고재무책임자(CFO)가 임시 CEO로 임명되었습니다 여기서 영구적인 후임자를 찾는 과정이 진행됩니다.

아론 롤린스 박사, 집행 의장은 회사의 비즈니스 모델과 성장 가능성에 대한 신뢰를 표현했습니다. 초점은 핵심 바디 윤곽 절차, 장기적인 마케팅 비용 감소 및 현재의 경제 환경에 대한 재정적 규율 강화를에 두게 됩니다. 덴니스 딘은 회사의 계획은 핵심 운영에 집중하고, 비용을 줄이며, 효율적인 확장을 위한 위치를 잡는 것이라고 강조했습니다. 이는 조건이 개선됨에 따라 일관된 수익 성장을 유지하는 것입니다.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), un fournisseur national de procédures de remodelage corporel haut de gamme, a annoncé des changements significatifs dans sa direction. Todd Magazine a démissionné de son poste de directeur général et membre du conseil d'administration, passant à un rôle consultatif jusqu'au 31 décembre 2024. Dennis Dean, le directeur financier de l'entreprise, a été nommé directeur général par intérim pendant que la recherche d'un successeur permanent est en cours.

Le Dr Aaron Rollins, président exécutif, a exprimé sa confiance dans le modèle économique de l'entreprise et son potentiel de croissance. L'accent sera mis sur les procédures de remodelage corporel essentielles, la réduction des dépenses marketing à long terme et l'augmentation de la discipline financière en réponse à l'environnement économique actuel. Dennis Dean a souligné le plan de l'entreprise de se concentrer sur les opérations de base, réduire les dépenses et se positionner pour une mise à l'échelle efficace afin de garantir une croissance des revenus constante avec des marges EBITDA leaders dans l'industrie à mesure que les conditions s'améliorent.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), ein nationaler Anbieter von Premium-Körperformungsverfahren, hat bedeutende Veränderungen in der Führung angekündigt. Todd Magazine hat als Chief Executive Officer und Mitglied des Vorstands zurückgetreten und wird bis zum 31. Dezember 2024 in eine beratende Rolle wechseln. Dennis Dean, der Chief Financial Officer des Unternehmens, wurde als Interims-CEO ernannt, während die Suche nach einem dauerhaften Nachfolger durchgeführt wird.

Dr. Aaron Rollins, Executive Chairman, äußerte Vertrauen in das Geschäftsmodell und das Wachstumspotenzial des Unternehmens. Der Fokus wird auf den Kernverfahren zur Körperformung, der Reduzierung der langfristigen Marketingausgaben sowie der Erhöhung der finanziellen Disziplin im Hinblick auf das aktuelle wirtschaftliche Umfeld gelegt. Dennis Dean betonte den Plan des Unternehmens, sich auf die Kernoperationen zu konzentrieren, Ausgaben zu senken und sich für eine effiziente Skalierung zu positionieren, um ein konstantes Umsatzwachstum mit branchenführenden EBITDA-Margen zu erzielen, während sich die Bedingungen verbessern.

Positive
  • Appointment of CFO Dennis Dean as interim CEO ensures continuity in leadership
  • Focus on core body contouring procedures may lead to improved operational efficiency
  • Plans to reduce expenses and increase fiscal discipline could improve profitability
  • Strategy to scale more efficiently aims to deliver consistent revenue growth
Negative
  • Sudden departure of CEO Todd Magazine may create short-term uncertainty
  • Reduction in long-term marketing spend could potentially impact future growth
  • Acknowledgment of a 'dynamic economic environment' suggests potential market challenges

MIAMI BEACH, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced Todd Magazine has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors of the Company. Mr. Magazine will serve as an advisor to the Company through December 31, 2024. Dennis Dean, Chief Financial Officer has assumed the position of interim Chief Executive Officer until a permanent successor is named.

Dr. Aaron Rollins, Executive Chairman of the Board stated: “I am confident in our business model and see tremendous opportunity to expand upon our Company’s competitive strengths and proprietary technology to enable AirSculpt to achieve a higher level of growth in the future. I am also pleased to announce that Dennis Dean, Chief Financial Officer has assumed the position of Interim CEO while we conduct a search for a permanent successor. Dennis is the right choice for this position as we focus on our core body contouring procedures, remove long-term oriented marketing spend and increase fiscal discipline as we navigate a dynamic economic environment. I want to thank Todd for his leadership and contributions over the past 18 months and look forward to continuing to benefit from his insight as an advisor.”

Dennis Dean, stated: “I am honored to assume an interim CEO role and excited about our long-term potential. In the near term, we will execute our plan to focus on our core operations and reduce expenses so that we are positioned to scale more efficiently and return to the delivery of consistent revenue growth at industry leading EBITDA margins as the external environment improves.”

Todd Magazine stated, “It has been rewarding to work alongside the Board and the entire AirSculpt team. I am a big believer in AirSculpt with its unique procedures that help our patients to lead happier, healthier and more productive lives. Over the next few months my top priority is to ensure a smooth transition. I look forward to seeing the Company achieve its goals in the coming years.”

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

To learn more about AirSculpt Technologies, please visit the Company's website at https://investors.elitebodysculpture.com. AirSculpt Technologies uses its website as a channel of distribution for material Company information. Financial and other material information regarding AirSculpt Technologies is routinely posted on the Company's website and is readily accessible.

Forward-Looking Statements

This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies, and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. You are cautioned that there are important risks and uncertainties, many of which are beyond our control, that could cause our actual results, level of activity, performance, or achievements to differ materially from the projected results, level of activity, performance or achievements that are expressed or implied by such forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements, including those factors discussed in the section titled “Risk Factors” in our Annual Report on Form 10-K.

Our future results could be affected by a variety of other factors, including, but not limited to, failure to open and operate new centers in a timely and cost-effective manner; inability to open new centers due to rising interest rates and increased operating expenses due to rising inflation; increased competition in the weight loss and obesity solutions market, including as a result of the recent regulatory approval, increased market acceptance, availability and customer awareness of weight-loss drugs; shortages or quality control issues with third-party manufacturers or suppliers; competition for surgeons; litigation or medical malpractice claims; inability to protect the confidentiality of our proprietary information; changes in the laws governing the corporate practice of medicine or fee-splitting; changes in the regulatory, macroeconomic conditions, including inflation and the threat of recession, economic and other conditions of the states and jurisdictions where our facilities are located; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.

The risk factors discussed in “Item 1A. Risk Factors” in our Annual Report on Form 10-K and in other filings we make from time to time with the U.S. Securities and Exchange Commission could cause our results to differ materially from those expressed in the forward-looking statements made in this press release.

There also may be other risks and uncertainties that are currently unknown to us or that we are unable to predict at this time.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Forward-looking statements represent our estimates and assumptions only as of the date they were made, which are inherently subject to change, and we are under no duty and we assume no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated after the date of this press release to conform our prior statements to actual results or revised expectations, except as required by law. Given these uncertainties, investors should not place undue reliance on these forward-looking statements.

Investor Contact
Allison Malkin
ICR, Inc.
airsculpt@icrinc.com


FAQ

Why did Todd Magazine step down as CEO of AirSculpt Technologies (AIRS)?

The press release does not specify the reason for Todd Magazine's departure. However, it states that he will serve as an advisor to AirSculpt Technologies (AIRS) through December 31, 2024, ensuring a smooth transition.

Who is the new CEO of AirSculpt Technologies (AIRS)?

Dennis Dean, the Chief Financial Officer of AirSculpt Technologies (AIRS), has been appointed as the interim CEO while the company conducts a search for a permanent successor.

What changes in strategy has AirSculpt Technologies (AIRS) announced?

AirSculpt Technologies (AIRS) has announced a focus on core body contouring procedures, reduction of long-term marketing spend, increased fiscal discipline, and plans to reduce expenses to position the company for more efficient scaling and consistent revenue growth.

How might the leadership change affect AirSculpt Technologies' (AIRS) future performance?

While the immediate impact is uncertain, the company aims to improve operational efficiency, reduce expenses, and focus on core procedures. This strategy is intended to position AirSculpt Technologies (AIRS) for consistent revenue growth and industry-leading EBITDA margins as the economic environment improves.

AirSculpt Technologies, Inc.

NASDAQ:AIRS

AIRS Rankings

AIRS Latest News

AIRS Stock Data

405.18M
13.15M
26.54%
73.27%
2.74%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
MIAMI BEACH